Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$903,812
New position
Shares Held
18,853
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#550
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHSTAR ASSET MANAGEMENT Co holds $10,204,107 across 8 Drug Manufacturers - General names. NVO ranks #3 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,776 | $4,768,540 | |
| 2 | NVS |
Novartis AG
|
13,875 | $2,174,490 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
18,853 | $903,812 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,130 | $787,705 | |
| 5 | LLY |
ELI LILLY & Co
|
617 | $740,048 | |
| 6 | ABBV |
AbbVie Inc.
|
2,065 | $519,636 | |
| 7 | PFE |
Pfizer Inc
|
11,074 | $266,661 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
750 | $43,215 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $903,812 | 18,853 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||